BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Beckman Laser Institute - ECPv6.18.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://bli.uci.edu
X-WR-CALDESC:Events for Beckman Laser Institute
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20230312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20231105T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20240310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20241103T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20230316T120000
DTEND;TZID=America/Los_Angeles:20230316T130000
DTSTAMP:20230314T184923Z
CREATED:20230314T184923Z
LAST-MODIFIED:20230314T184923Z
UID:31214-1678968000-1678971600@bli.uci.edu
SUMMARY:Mehmet Cilingiroglu\, MD\, FSCAI\, FACC\, FESC
DESCRIPTION:Cardio-oncology; Cardiovascular diseases in cancer patients \nAbstract  \nWith more advances in cancer therapy\, more patients are alive as cancer survivors than a decade ago.\nHowever\, cardiovascular disease is the number one reason for mortality in these cancer free patients.\nBeside the conventional risk factors for cardiovascular diseases\, radiation and chemotherapy and\ncancer specific immunotherapy contributes to increased risk. We will discuss the details of\ncardiovascular disease etiologies and treatment options in this specific patient population. \nBiography \nDr. Cilingiroglu is a well-established interventional cardiologist and structural heart interventionalist.\nHe has academic affiliations with several different universities in the USA as well as in EU for various\nresearch and educational collaborations. Beside providing excellent clinical cardiovascular care\, over\nthe last two decades he has been involved and lead many different investigator initiated and novel\ndevice development studies. Have been collaborating with Professor Milner and his team for many\nyears. \nREGISTER HERE FOR ZOOM \n 
URL:https://bli.uci.edu/event/mehmet-cilingiroglu/
LOCATION:Zoom Event\, CA\, United States
CATEGORIES:LAMP Seminar
ATTACH;FMTTYPE=image/jpeg:https://bli.uci.edu/wp-content/uploads/2023/03/Mehmet.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20230330T090000
DTEND;TZID=America/Los_Angeles:20230330T100000
DTSTAMP:20230328T165742Z
CREATED:20230328T165357Z
LAST-MODIFIED:20230328T165742Z
UID:31224-1680166800-1680170400@bli.uci.edu
SUMMARY:Daniel Razansky\, Ph.D.
DESCRIPTION:Cardio-oncology; Advanced optoacoustic imaging methods for biomedical research and clinical diagnostics \nAbstract  \nOptoacoustic imaging has achieved remarkable progress over the last decade\, benefiting from coordinated developments in optical and ultrasound technology\, probe chemistry\, and imaging theory. The technique is increasingly attracting attention of the biomedical research community due to its excellent spatial and temporal resolution\, centimeter scale penetration into living tissues\, versatile endogenous and exogenous optical absorption contrast. State-of-the-art implementations of multispectral optoacoustic tomography are based on multi-wavelength excitation of tissues to visualize specific molecules within opaque tissues. As a result\, optoacoustics can noninvasively deliver structural\, functional\, metabolic\, and molecular information from living tissues. \nThe talk covers advances in optoacoustic microscopy and tomography instrumentation\, reconstruction algorithms for ultrafast imaging\, as well as synergistic combinations with fluorescence\, magnetic resonance and ultrasound methods. Efforts are underway to explore potential of the technique in studying multi-scale dynamics of the brain and heart\, monitoring of therapies\, targeted molecular imaging applications and clinical diagnostics of patients in a number of indications\, such as breast and skin lesions\, inflammatory diseases and cardiovascular diagnostics. \nBiography \nProfessor Daniel Razansky holds the Chair of Biomedical Imaging with double appointments at the Faculty of Medicine\, University of Zurich and Department of Information Technologies and Electrical Engineering\, ETH Zurich in Switzerland\, where he also serves as Director of the joint Preclinical Imaging Center. \nHe earned degrees in Biomedical and Electrical Engineering from the Technion – Israel Institute of Technology and conducted postdoctoral research at the Harvard Medical School. Previously\, he was Professor of Molecular Imaging Engineering at the Technical University of Munich and Helmholtz Center Munich in Germany. \nThe Razansky Lab pioneered a number of bio-imaging technologies that were successfully commercialized and put into use in research labs and clinical facilities across the globe\, among them the multi-spectral optoacoustic tomography (MSOT) and hybrid optoacoustic ultrasound (OPUS). His research has been recognized by the German Innovation Prize and multiple awards from the ERC\, NIH\, SNF\, DFG and HFSP. He is also Fellow of the IEEE\, SPIE and Optica Societies. \nREGISTER HERE FOR ZOOM \n 
URL:https://bli.uci.edu/event/daniel-razansky-phd/
LOCATION:Zoom Event\, CA\, United States
CATEGORIES:2023 Virtual Seminar Series
ATTACH;FMTTYPE=image/jpeg:https://bli.uci.edu/wp-content/uploads/2023/03/updated.jpg
END:VEVENT
END:VCALENDAR